Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections

<b>Aims:</b> Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate...

Full description

Bibliographic Details
Main Authors: Varaiya Ami, Dogra Jyotsana, Kulkarni Manasi, Bhalekar Pallavi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-07-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=3;spage=370;epage=372;aulast=Varaiya
_version_ 1818617936090234880
author Varaiya Ami
Dogra Jyotsana
Kulkarni Manasi
Bhalekar Pallavi
author_facet Varaiya Ami
Dogra Jyotsana
Kulkarni Manasi
Bhalekar Pallavi
author_sort Varaiya Ami
collection DOAJ
description <b>Aims:</b> Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. There is not much information on ESBL-producing organisms causing diabetic foot infection. An attempt was therefore made to study the ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot patients with type 2 diabetes mellitus. <b> Materials and Methods:</b> A total of 134 isolates of <i>E. coli</i> and <i>K. pneumoniae</i> were obtained from tissue, pus swab, and wound swab samples from diabetic foot ulcers submitted for routine microbiological analysis during the period January to December 2005 from patients with diabetic foot infections who had type 2 diabetes mellitus, attending S. L. Raheja Hospital. The above isolates were tested for antimicrobial susceptibility by disc diffusion technique according to clinical and laboratory standards institute (CLSI) guidelines. The screening for ESBL production was done by phenotypic confirmatory test using ceftazidime disc in the presence and absence of clavulanic acid as recommended by CLSI. <b> Results:</b> Among the 134 isolates, 54 (40.29&#x0025;) were <i>E. coli</i> and 80 (59.70&#x0025;) were <i>K. pneumoniae;</i> among which, ESBL production was detected in 31 (23.13&#x0025;) isolates. Of these 31, 15 (48.38&#x0025;) were <i>E. coli</i> and 16 (51.61&#x0025;) were <i>K. pneumoniae</i>. All the ESBL-producing isolates were found to be 100&#x0025; sensitive to carbapenem (imipenem and meropenem). Mortality was found to be 3.22&#x0025;, the cause of death being septicemia leading to multiple organ failure. <b> Conclusions:</b> The prevalence of ESBLs among members of <i>Enterobacteriaceae</i> constitutes a serious threat to the current beta-lactam therapy, leading to treatment failure and consequent escalation of costs. There is an urgent need to emphasize rational use of drugs to minimize the misuse of available antimicrobials.
first_indexed 2024-12-16T17:13:36Z
format Article
id doaj.art-b8d3437cbe324ba9abe8e6ce87d9a0a7
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-12-16T17:13:36Z
publishDate 2008-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-b8d3437cbe324ba9abe8e6ce87d9a0a72022-12-21T22:23:21ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292008-07-01513370372Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infectionsVaraiya AmiDogra JyotsanaKulkarni ManasiBhalekar Pallavi<b>Aims:</b> Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. There is not much information on ESBL-producing organisms causing diabetic foot infection. An attempt was therefore made to study the ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot patients with type 2 diabetes mellitus. <b> Materials and Methods:</b> A total of 134 isolates of <i>E. coli</i> and <i>K. pneumoniae</i> were obtained from tissue, pus swab, and wound swab samples from diabetic foot ulcers submitted for routine microbiological analysis during the period January to December 2005 from patients with diabetic foot infections who had type 2 diabetes mellitus, attending S. L. Raheja Hospital. The above isolates were tested for antimicrobial susceptibility by disc diffusion technique according to clinical and laboratory standards institute (CLSI) guidelines. The screening for ESBL production was done by phenotypic confirmatory test using ceftazidime disc in the presence and absence of clavulanic acid as recommended by CLSI. <b> Results:</b> Among the 134 isolates, 54 (40.29&#x0025;) were <i>E. coli</i> and 80 (59.70&#x0025;) were <i>K. pneumoniae;</i> among which, ESBL production was detected in 31 (23.13&#x0025;) isolates. Of these 31, 15 (48.38&#x0025;) were <i>E. coli</i> and 16 (51.61&#x0025;) were <i>K. pneumoniae</i>. All the ESBL-producing isolates were found to be 100&#x0025; sensitive to carbapenem (imipenem and meropenem). Mortality was found to be 3.22&#x0025;, the cause of death being septicemia leading to multiple organ failure. <b> Conclusions:</b> The prevalence of ESBLs among members of <i>Enterobacteriaceae</i> constitutes a serious threat to the current beta-lactam therapy, leading to treatment failure and consequent escalation of costs. There is an urgent need to emphasize rational use of drugs to minimize the misuse of available antimicrobials.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=3;spage=370;epage=372;aulast=Varaiya<i>Escherichia coli</i>extended-spectrum beta-lactamase<i>Klebsiella pneumoniae </i>
spellingShingle Varaiya Ami
Dogra Jyotsana
Kulkarni Manasi
Bhalekar Pallavi
Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
Indian Journal of Pathology and Microbiology
<i>Escherichia coli
</i>extended-spectrum beta-lactamase
<i>Klebsiella pneumoniae </i>
title Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
title_full Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
title_fullStr Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
title_full_unstemmed Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
title_short Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
title_sort extended spectrum beta lactamase producing i escherichia coli i and i klebsiella pneumoniae i in diabetic foot infections
topic <i>Escherichia coli
</i>extended-spectrum beta-lactamase
<i>Klebsiella pneumoniae </i>
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=3;spage=370;epage=372;aulast=Varaiya
work_keys_str_mv AT varaiyaami extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections
AT dograjyotsana extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections
AT kulkarnimanasi extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections
AT bhalekarpallavi extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections